|
Is the Schizophrenia Mortality Study in The Lancet CREDIBLE? |
|
|
|
Friday, 17 July 2009 |
|
Unless the overall treatment and services provided to schizophrenia
patients in Finland is unique and especially protective—which the
authors do not suggest—their claimed findings of lowered mortality rates for antipsychotic drug users are belied by a
consistent body of evidence.
|
|
Read more...
|
|
|
World Conference Science Journalists |
|
|
|
Tuesday, 14 July 2009 |
So far as I can tell, the panel that I was asked to participate in was
the only one that focused on the pharmaceutical industry.
|
|
Read more...
|
|
|
Systematic Review: Faulty Clinical Trial Analyses Favor new toxic drugs |
|
|
|
Tuesday, 12 May 2009 |
Two important analyses in Open Medicine , a peer-reviewed, independent,
open-access journal, focus on methodological flaws in data analysis of
randomized drug trials.
|
|
Read more...
|
|
|
AHRP Letter to Harvard Re: Dr. Biederman's Research |
|
|
|
Monday, 20 April 2009 |
|
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman's publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies.
|
|
Read more...
|
|
|
The Damaging Impact of PDUFA and Why It Should be Repealed |
|
|
|
Tuesday, 20 March 2007 |
|
The re-prioritization of rapid approvals occurred at the expense of drug safety standards, |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 Next > End >>
|
| Results 19 - 27 of 29 |
